Literature DB >> 2458364

A431 cell variants lacking the blood group A antigen display increased high affinity epidermal growth factor-receptor number, protein-tyrosine kinase activity, and receptor turnover.

L H Defize1, D J Arndt-Jovin, T M Jovin, J Boonstra, J Meisenhelder, T Hunter, H T de Hey, S W de Laat.   

Abstract

The epidermal growth factor receptor (EGF-R) of human A431 cells bears an antigenic determinant that is closely related to the human blood group A carbohydrate structure. Labeling studies with blood group A reactive anti-EGF-R monoclonal antibodies and various lectins revealed that A431 cultures are heterogeneous with respect to blood group A expression. We have isolated clonal variants of these cells that either express (A431A+ cells) or completely lack (A431A- cells) the blood group A specific N-acetyl-D-galactosamine (GalNAc) residue. We show that this difference is due to the absence of a UDP-GalNAc:Gal transferase activity in A431A- cells. Subsequently, we have compared EGF-R functioning in these cell lines. Scatchard analysis of EGF-binding shows that in A431A- cells 6.3% of the EGF-R belongs to a high affinity subclass (Kd = 0.4 nM) while in A431A+ this subclass represents only 3.2% of the total receptor pool. The elevated level of high affinity receptors in A431A- cells is accompanied by a parallel increase in receptor protein- tyrosine kinase activity. In membrane preparations of A431A- cells, receptor autophosphorylation as well as phosphorylation of a tyrosine-containing peptide substrate is 2-3-fold higher as compared with A431A+ cells. In intact A431A-cells, the difference in receptor activity is measured as a 2-3-fold elevated level of receptor phosphorylation and a 2-3-fold higher abundance of phosphotyrosine in total cellular protein in A431A- cells. In addition, [35S]methionine pulse-chase experiments showed a ligand-independent increase in turnover of EGF-R in A431A- cells: the receptor's half life in these cells is 10 h as compared with 17 h in A431A+ cells. Our results suggest a possible involvement of GalNAc residue(s) in determining EGF-R affinity, protein-tyrosine kinase activity and turnover in A431 cells. Furthermore, our results indicate that high affinity EGF-R are the biologically active species with respect to protein-tyrosine kinase activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458364      PMCID: PMC2115284          DOI: 10.1083/jcb.107.3.939

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  39 in total

1.  Characterization of Rous sarcoma virus src gene products synthesized in vitro.

Authors:  K Beemon; T Hunter
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

2.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

3.  Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor.

Authors:  P J Parker; S Young; W J Gullick; E L Mayes; P Bennett; M D Waterfield
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

4.  Biological role of epidermal growth factor-receptor clustering. Investigation with monoclonal anti-receptor antibodies.

Authors:  A B Schreiber; T A Libermann; I Lax; Y Yarden; J Schlessinger
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

5.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.

Authors:  T Kawamoto; J D Sato; A Le; J Polikoff; G H Sato; J Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

6.  Monoclonal antibody reactive with the human epidermal-growth-factor receptor recognizes the blood-group-A antigen.

Authors:  H C Gooi; J Schlessinger; I Lax; Y Yarden; T A Libermann; T Feizi
Journal:  Biosci Rep       Date:  1983-11       Impact factor: 3.840

7.  A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles.

Authors:  S Cohen; H Ushiro; C Stoscheck; M Chinkers
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

8.  A monoclonal antibody that precipitates the glycoprotein receptor for epidermal growth factor is directed against the human blood group H type 1 antigen.

Authors:  P Fredman; N D Richert; J L Magnani; M C Willingham; I Pastan; V Ginsburg
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

9.  Biosynthesis of the epidermal growth factor receptor in A431 cells.

Authors:  E L Mayes; M D Waterfield
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

10.  Properties of a monoclonal antibody to epidermal growth factor receptor with implications for the mechanism of action of EGF.

Authors:  M Gregorou; A R Rees
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  14 in total

1.  Single-molecule analysis of epidermal growth factor binding on the surface of living cells.

Authors:  Yuji Teramura; Junya Ichinose; Hiroaki Takagi; Kenji Nishida; Toshio Yanagida; Yasushi Sako
Journal:  EMBO J       Date:  2006-08-31       Impact factor: 11.598

2.  The influence of lactation products on the temporal expression of histo-blood group antigens in the intestines of suckling pigs: lectin histochemical and immunohistochemical analysis.

Authors:  D Kelly; T P King
Journal:  Histochem J       Date:  1991-01

Review 3.  Blood group antigens: molecules seeking a function?

Authors:  P Greenwell
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

4.  Graphene nanoribbons elicit cell specific uptake and delivery via activation of epidermal growth factor receptor enhanced by human papillomavirus E5 protein.

Authors:  Sayan Mullick Chowdhury; Prady Manepalli; Balaji Sitharaman
Journal:  Acta Biomater       Date:  2014-06-27       Impact factor: 8.947

5.  Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells.

Authors:  Ying-Chih Liu; Hsin-Yung Yen; Chien-Yu Chen; Chein-Hung Chen; Ping-Fu Cheng; Yi-Hsiu Juan; Chung-Hsuan Chen; Kay-Hooi Khoo; Chong-Jen Yu; Pan-Chyr Yang; Tsui-Ling Hsu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

6.  A novel mechanism for isoprenaline-stimulated proliferation of rat parotid acinar cells involving the epidermal growth factor receptor and cell surface galactosyltransferase.

Authors:  K R Purushotham; W A Dunn; C A Schneyer; M G Humphreys-Beher
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

7.  Epidermal growth factor-stimulated calcium ion transients in individual A431 cells: initiation kinetics and ligand concentration dependence.

Authors:  T E Cheyette; D J Gross
Journal:  Cell Regul       Date:  1991-10

8.  Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.

Authors:  Fred R Hirsch; Rafal Dziadziuszko; Nick Thatcher; Helen Mann; Claire Watkins; Dinah V Parums; Georgina Speake; Brian Holloway; Paul A Bunn; Wilbur A Franklin
Journal:  Cancer       Date:  2008-03-01       Impact factor: 6.860

9.  Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation.

Authors:  T W Gadella; T M Jovin
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

10.  Single-molecule imaging and fluorescence lifetime imaging microscopy show different structures for high- and low-affinity epidermal growth factor receptors in A431 cells.

Authors:  Stephen E D Webb; Selene K Roberts; Sarah R Needham; Christopher J Tynan; Daniel J Rolfe; Martyn D Winn; David T Clarke; Roger Barraclough; Marisa L Martin-Fernandez
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.